ContractOffer Letter Agreement • November 7th, 2019 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 7th, 2019 Company Industry
LICENSE AGREEMENT DATED AS OF May 10, 2019 BY AND AMONG THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA AND THE CHILDREN’S HOSPITAL OF PHILADELPHIA ANDLicense Agreement • November 7th, 2019 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledNovember 7th, 2019 Company Industry JurisdictionThis License Agreement (this “Agreement”) is dated as of May 10, 2019 (the “Effective Date”) by and among The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), The Children’s Hospital of Philadelphia (“CHOP”) (Penn and CHOP, collectively, “Institutions”), and Eiger BioPharmaceuticals, Inc., a Delaware corporation (“Licensee”). Institutions and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”.